SynektikWAR:SNT +1.43%85 Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus rates WAR:SNT with a GF Score™ of 85/100 and a GF Value™ of zł227.58 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 465 Medical Devices & Instruments companies, Synektik ranks better than 68.82% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Synektik's
Operating Income
for the
three
months ended in Mar. 2026 was zł54.0 Mil. Synektik's Interest Expense for the
three
months ended in Mar. 2026 was zł0.5 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Synektik's Interest Coverage or its related term are showing as below:
WAR:SNT'
s Interest Coverage Range Over the Past 10 Years
Min: 3.62 Med: 18.14 Max: 89.05
Current: 57.69
WAR:SNT's Interest Coverage is ranked better than 68.82% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 16.03
vs WAR:SNT: 57.69
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Synektik Interest Coverage Related Terms
Synektik Interest Coverage Historical Data
* Premium members only.
The historical data trend for Synektik's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
WAR:SNT vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Synektik's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synektik Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Synektik's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Synektik's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Synektik (WAR:SNT) has a Interest Coverage of 0 (At Loss) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Synektik and its competitors. Over the past decade, Synektik's Interest Coverage has ranged from 3.62 to 89.05. According to the industry distribution chart, Synektik ranks #145 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 31.2%.
Is Synektik's Interest Coverage too high?
Synektik's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 3.62 to a high of 89.05. Based on the distribution chart, Synektik ranks #145 out of 465 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Synektik has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Synektik's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Synektik ranks #145 out of 465 companies for Interest Coverage. This puts Synektik in the upper half of its industry. The industry median Interest Coverage is 16.03. Historically, Synektik's own Interest Coverage has ranged from 3.62 to 89.05 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.03, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Synektik and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synektik's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synektik stock overvalued right now?
Based on GuruFocus' analysis, Synektik (WAR:SNT) is currently considered Significantly Overvalued. The stock's GF Value™ is zł227.58, compared to a current price of zł381.80 — trading 67.8% above its estimated fair value. The current Interest Coverage is 0 (At Loss). Synektik's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Synektik (WAR:SNT), the current Interest Coverage is 0 (At Loss) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synektik (WAR:SNT) Overvalued in 2026?
Based on GuruFocus' analysis, Synektik stock appears to be overvalued.
The current stock price of zł381.80 is trading 67.8% above its estimated GF Value™ of zł227.58.
GuruFocus considers Synektik to be Significantly Overvalued.
Key valuation signals for WAR:SNT:
Interest Coverage: 0 (At Loss)
GF Value™: zł227.58 vs. price of zł381.80 (67.8% above fair value)
No single metric tells the full story. See the WAR:SNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
85GF Score
Get the complete analysis for WAR:SNT
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SNT has been successfully added to your 
